65 related articles for article (PubMed ID: 28461158)
1. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21.
Yang XP; Liu SL; Xu JF; Cao SG; Li Y; Zhou YB
Exp Cell Res; 2017 Aug; 357(1):79-87. PubMed ID: 28461158
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV
Br J Cancer; 2016 Feb; 114(3):269-80. PubMed ID: 26766740
[TBL] [Abstract][Full Text] [Related]
3. The Regulatory Role of
Chen F; Zheng Y; Zhou H; Li C
Cancer Biother Radiopharm; 2024 Apr; 39(3):211-222. PubMed ID: 35802495
[No Abstract] [Full Text] [Related]
4. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer.
Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199452
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.
Danilkovitch-Miagkova A; Zbar B
J Clin Invest; 2002 Apr; 109(7):863-7. PubMed ID: 11927612
[No Abstract] [Full Text] [Related]
6. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract][Full Text] [Related]
7. Correction: Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1.
Coetzee AS; Carter EP; Rodríguez-Fernández L; Heward J; Wang Q; Karim SA; Boughetane L; Milton C; Uyulur F; Morton JP; Kocher HM; Grose RP
Oncogene; 2023 Feb; 42(7):545. PubMed ID: 36670196
[No Abstract] [Full Text] [Related]
8. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo.
Komar HM; Serpa G; Kerscher C; Schwoegl E; Mace TA; Jin M; Yang MC; Chen CS; Bloomston M; Ostrowski MC; Hart PA; Conwell DL; Lesinski GB
Sci Rep; 2017 May; 7(1):1787. PubMed ID: 28496202
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stellate cells: what's new?
Pang TCY; Wilson JS; Apte MV
Curr Opin Gastroenterol; 2017 Sep; 33(5):366-373. PubMed ID: 28590306
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in pancreatic cancer: Impact of altered energy metabolism.
Grasso C; Jansen G; Giovannetti E
Crit Rev Oncol Hematol; 2017 Jun; 114():139-152. PubMed ID: 28477742
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology in peripheral nerve repair and reconstruction.
Carvalho CR; Silva-Correia J; Oliveira JM; Reis RL
Adv Drug Deliv Rev; 2019 Aug; 148():308-343. PubMed ID: 30639255
[No Abstract] [Full Text] [Related]
12. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells
Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H
Front Oncol; 2023; 13():1138238. PubMed ID: 37182151
[TBL] [Abstract][Full Text] [Related]
13. CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer.
Geng F; Dong L; Bao X; Guo Q; Guo J; Zhou Y; Yu B; Wu H; Wu J; Zhang H; Yu X; Kong W
Mol Ther Oncolytics; 2022 Sep; 26():304-313. PubMed ID: 36090474
[TBL] [Abstract][Full Text] [Related]
14. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition.
Cannone S; Greco MR; Carvalho TMA; Guizouarn H; Soriani O; Di Molfetta D; Tomasini R; Zeeberg K; Reshkin SJ; Cardone RA
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954400
[TBL] [Abstract][Full Text] [Related]
15. Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation.
Swadling JB; Warnecke T; Morris KL; Barr AR
Biophys J; 2022 Jun; 121(12):2312-2329. PubMed ID: 35614852
[TBL] [Abstract][Full Text] [Related]
16. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway.
Ma Z; Li Z; Wang S; Zhou Z; Liu C; Zhuang H; Zhou Q; Huang S; Zhang C; Hou B
J Exp Clin Cancer Res; 2022 Apr; 41(1):130. PubMed ID: 35392973
[TBL] [Abstract][Full Text] [Related]
17. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment.
Li Y; Zhang J; Xu J; Liu S
Front Oncol; 2021; 11():759376. PubMed ID: 34976805
[TBL] [Abstract][Full Text] [Related]
18. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance.
Xelwa N; Candy GP; Devar J; Omoshoro-Jones J; Smith M; Nweke EE
Front Oncol; 2021; 11():683788. PubMed ID: 34195085
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials.
Mejia I; Bodapati S; Chen KT; Díaz B
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33050151
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
